Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Acta Neuropathol. 2013 Nov 17;127(5):731–745. doi: 10.1007/s00401-013-1212-8

Fig. 4. Divergence of clinical outcome after first recurrence is associated with PF EPN sub-group designation at diagnosis.

Fig. 4

Kaplan-Meier plots demonstrate (a) a significantly shorter overall survival (OS) in Group A than Group B PF EPN, (b) no sub-group difference in time to first recurrence after diagnosis, and (c) a significant worse progression-free survival in Group A following first recurrence. Statistical significance was determined by log-rank test. (d) Resectability of tumors shows no significant sub-group association at diagnosis. (e) At recurrence, Group A tumors are significantly less resectable.